Tonight on Nightly Business Report, Sprint shares fall almost 20% after ending its bid for T-Mobile. Now, the company has to find new growth the hard way. And, what happens when unapproved drugs are the only hope for very ill patients. Tonight we start a three-part series "desperate measures."